ZYME
Zymeworks Inc.
NASDAQ · Healthcare · Biotechnology · CA
$29.19
−2.37%Forward multiples
Based on analyst estimates
- P/E forward
- 9.85x
- P/E 2026E
- 20.14x
- P/E 2027E
- 22.51x
- P/E 2028E
- 76.12x
- P/S forward
- 4.42x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 25.77x
- Price / sales
- 55.79x
- Price / cash flow
- -17.40x
Enterprise value
- Enterprise value
- $2.1B
- EV / sales
- 55.73x
- EV / EBITDA
- -14.79x
- EV / EBIT
- -13.30x
- Market cap
- $2.1B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026